Diabetes Medications and Treatment Guidelines - lots to it !!!
Key documents
- Barnsley Treatment Algorithm For The Management Of Type 2 Diabetes V2
- The De Fronzo Treatment Algorithm For The Management Of Type 2 Diabetes
- Barnsley Health Community Guidelines For The Management Of Type 2 Diabetes
- Type 2 Diabetes And Renal Impairment
- Metformin
- Sulfonylureas
- Gliptins DPP 4 Inhibitors
- Thiazolidinediones Glitazones
- GLP 1
- SGLT2 Inhibitors
- Insulin Pens And Needles
- Helpline Numbers Insulin Companies
External Links
Related pages and links
- Management of Young Adults (18-39 years) with Type 2 Diabetes Algorithm
- Diabetes: Antiplatelet treatment in diabetes
- Metformin CKS NICE prescribing guideline
- Sulfonylurea CKS NICE prescribing guideline
- Pioglitazone CKS NICE prescribing guideline
- SGLT2 Inhibitors CKS NICE prescribing guideline
- Diabetes: Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2 inhibitors) and risk of Diabetic Ketoacidosis DKA
- DPP-4 Inhibitors ('gliptins') in Type 2 Diabetes
- Gliptins DDP4 Inhibitors CKS NICE prescribing guideline
- GLP1 Agonist (APC Approved)
- GLP1 receptor agonist CKS NICE prescribing guideline
- Tirzepatide in diabetes Amber-G guideline
- Diabetes and Insulin Therapy
- Diabetes: Insulin Therapy for Type 2 Diabetes
- Diabetes: Needles for Pre-filled and Reusable Pens
- Diabetes Hybrid Closed Loop Guidance
- Insulin Aspart (Fiasp)
- Tresiba long acting insulin
- Toujeo High strength Insulin glargine for adults and children over 6years.
- Finerenone shared care guidelines in patients with CKD and type 2 diabetes
- Finerenone CKS NICE prescribing guideline
-
Clinical support group
-
Endocrine and Diabetes
-
Do you want to add this to your CPD record?
Add this to your CPD Record
Please log in to update your CPD Record.
Did you find this page helpful?